Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification.
暂无分享,去创建一个
Jackie S. Scott | Alan Wise | A. Muir | G. Sanger | T. Heightman | J. Witherington | A. Wise | Lee Abberley | Tom D Heightman | Sharon Butler | Fiona McKay | Alison Muir | Ben Powney | Kim Winborn | C. Campbell | Maite de Los Frailes | Jason Witherington | D. Dean | Sharon Butler | Vincent Bordas | Ben Powney | Jackie S Scott | Mark Longley | David K Dean | Richard Elliott | Gail Hutley | Barry Passingham | Manuela Berlanga | Maite de Los Frailes | Christopher Gardner | Jill Darton | Colin Campbell | Gareth Sanger | R. Elliott | Gail Hutley | L. Abberley | Manuela Berlanga | V. Bordas | B. Passingham | Fiona McKay | Mark J. Longley | Kim Y Winborn | Jill Darton | C. Gardner | D. K. Dean
[1] A. Brown,et al. 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist. , 1999, Journal of medicinal chemistry.
[2] P. Carpino. Recent developments in ghrelin receptor (GHS-R1a) agonists and antagonists , 2002 .
[3] K. Nakao,et al. Ghrelin strongly stimulates growth hormone release in humans. , 2000, The Journal of clinical endocrinology and metabolism.
[4] M. Kamm,et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study , 2005, Gut.
[5] Paul W Smith,et al. Identification of a potent and selective 5-HT1B receptor antagonist. , 2005, Bioorganic & medicinal chemistry letters.
[6] G. Sanger,et al. Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat , 2006, The Journal of physiology.
[7] D. Johnston,et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] T. Peeters. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. , 2006, Current opinion in pharmacology.
[9] S. Toler,et al. Preclinical pharmacology of CP-424,391, and orally active pyrazolinone-piperidine growth hormone secretagogue , 2001, Endocrine.
[10] M. Tschöp,et al. Ghrelin induces adiposity in rodents , 2000, Nature.
[11] G. Sanger,et al. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin , 2006, Neuroscience Letters.
[12] J. Nagamine,et al. Oxindole derivatives as orally active potent growth hormone secretagogues. , 2001, Journal of medicinal chemistry.
[13] M. Nakazato,et al. A role for ghrelin in the central regulation of feeding , 2001, Nature.